Advanced Biomed Inc. (NASDAQ:ADVB) Stock Short Interest Drops 39.8%

Advanced Biomed Inc. (NASDAQ:ADVB) saw a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 9,845 shares, a drop of 39.8% from the August 31st total of 16,357 shares. Approximately 0.8% of the company’s shares are sold short. Based on an average daily trading volume, of 110,241 shares, the days-to-cover ratio is currently 0.1 days.

Advanced Biomed Stock Performance

Shares of ADVB stock opened at $6.32 on Wednesday. The stock has a 50 day moving average price of $8.85 and a 200 day moving average price of $6.35. Advanced Biomed has a 52-week low of $3.61 and a 52-week high of $24.23. The firm has a market capitalization of $10.44 million, a P/E ratio of 1.31 and a beta of -0.29.

Analysts Set New Price Targets

ADVB has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Advanced Biomed to a “hold” rating in a research report on Saturday, August 22nd. Weiss Ratings raised shares of Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, July 23rd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.